# Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML

> **NCT01274195** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 27 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Busulfan

## Key facts

- **NCT ID:** NCT01274195
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01274195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01274195, "Hematopoietic Stem Cell Transplantation With Targeted Busulfan and Fludarabine in Pediatric AML". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01274195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*